Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy
ACS Nano · 20.11.2026
DOI: 10.1021/acsnano.6c18896 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 20.11.2026. Verfasst von Wen-Fang Song und 7 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Substantial efforts in adoptive T-cell therapy have centered on boosting T-cell activity against tumors. However, a crucial yet overlooked factor is that the onset and maintenance of T-cell responses are highly dependent on innate immunity. Here, we developed a strategy of engineering tumors with bacterial antigens via click chemistry to cross-regulate innate-adaptive immunity, thereby enhancing the efficacy of adoptive T-cell therapy in solid tumors. The targeted delivery of bacterial antigens is mediated by azido sugar liposomes (TALP) for introducing azide groups on tumors and dibenzocyclooctyne-decorated bacterial membranes (DBCO-BM) to endow tumor cells with the innate immunogenicity of bacteria. Our study reveals that tumors with exposed bacterial antigens trigger innate immune responses for direct tumor killing and drive T-cell tumor infiltration to launch adaptive immunity. The antitumor functions of adoptive T cells are significantly augmented with the cross-activation of innate-adaptive immunity. This study highlights the potential of innate immunity in addressing the suboptimal response of adoptive T cells in solid tumors.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, W., Li, R., Ji, P., Li, W., Yao, W., Feng, J., Zeng, X., & Zhang, X. (2026). Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy. ACS Nano. https://doi.org/10.1021/acsnano.6c18896
Vancouver
Song W, Li R, Ji P, Li W, Yao W, Feng J, et al. Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy. ACS Nano. 2026. doi:10.1021/acsnano.6c18896
BibTeX
@article{Song2026,
author = {Song, Wen-Fang and Li, Rui-Lin and Ji, Ping and Li, Wen and Yao, Wei-Qin and Feng, Jun and Zeng, Xuan and Zhang, Xian-Zheng},
title = {Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c18896}
}
EUVIMED